M

McKesson

Supplies medicines and technology to healthcare teams

Vice President - Health Systems, Intrafusion

Full-Time
$211.4k - $352.3k+ Annual bonus + Long-term incentive opportunities
Expert
Bachelor's
Remote in USA+1 moreMore locations: The Woodlands, TX, USA
RemoteRemote within the United States, with 50% national travel.
Sales & Account ManagementAccount Management

About the job

Requirements
  • A degree or equivalent experience is required.
  • Typically, 12 or more years of professional experience and 4 or more years of management experience are required.
  • At least 10 years of experience in health system sales, infusion services, specialty pharmacy, or provider solutions is required.
  • Demonstrated experience leading and coaching commercial teams is required.
  • Proven success managing complex, enterprise healthcare transactions is required.
  • A strong understanding of health system operating environments and infusion economics is required.
  • Ability to operate effectively in a highly matrixed organization is required.
  • The position is open to candidates residing anywhere in the United States.
  • The role requires 50% national travel.
Responsibilities
  • Lead, coach, and develop a team of sales and support resources aligned to Health Systems Intrafusion opportunities.
  • Set clear priorities, expectations, and performance objectives to support consistent execution and professional growth.
  • Conduct regular pipeline, deal strategy, and performance discussions to drive accountability and results.
  • Support onboarding and development of team members in partnership with Human Resources and functional leaders.
  • Lead complex, multi-stakeholder health system pursuits from opportunity qualification through contract execution.
  • Participate in executive-level customer discussions, presentations, and negotiations.
  • Guide opportunity structuring, scope definition, and value articulation for Intrafusion management and advisory services.
  • Partner with Finance, Legal, and Implementation teams to support pricing, contracting, and approvals within established governance processes.
  • Coordinate closely with operational and clinical subject-matter experts to ensure proposed solutions are operationally viable.
  • Align operational assessments and solution design with customer goals and implementation readiness.
  • Support effective transition from sales to implementation and remain engaged through early execution to ensure successful outcomes.
  • Build and maintain strong executive-level relationships within assigned health system customers.
  • Represent Intrafusion in customer meetings and internal forums.
  • Collaborate with McKesson Health Systems leadership to ensure alignment across enterprise relationships.
  • Manage day-to-day pipeline activity across assigned accounts.
  • Ensure opportunities are appropriately qualified and progressed through the sales process.
  • Maintain accurate forecasting and visibility into risks, dependencies, and resource needs.
  • Work closely with McKesson Health Systems, Operations, Revenue Cycle, Analytics, and Implementation teams to deliver coordinated customer solutions.
  • Promote consistent sales process discipline and governance compliance.
Desired Qualifications
  • Experience partnering cross-functionally with operations, clinical, finance, and implementation teams on enterprise-level healthcare deals.
  • Knowledge of infusion management, in-office infusion centers, or specialty pharmacy services.

About the company

McKesson distributes medicines and medical supplies to pharmacies, hospitals and other care providers, alongside services that connect drug manufacturers with patients. Its specialty businesses support community cancer care and clinical research, extending its work beyond moving products through warehouses. The company buys drugs and supplies from manufacturers for resale, while its software helps pharmacies manage inventory and healthcare teams secure insurance approval for prescriptions. It also sells practice management and patient support services to clinicians and drugmakers. McKesson traces its business roots to 1833 and is headquartered in Irving, Texas.

Company Size

10,001+

Company Stage

IPO

Headquarters

Irving, Texas

Founded

1833

Get referred to McKesson

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Reinvestment has cash behind it: McKesson reported $6.2 billion operating cash flow for fiscal 2026 in May 2026.
  • Specialty expansion drives growth: McKesson reported 31% higher fiscal 2026 Oncology and Multispecialty sales in May 2026.
  • Technical candidates have openings: McKesson lists 154 information technology jobs on its career site in October 2026.

What critics are saying

  • One customer holds bargaining power: CVS generated 24% of McKesson's fiscal 2026 revenue, reported in May 2026.
  • Technology jobs face cuts: McKesson approved prescription technology headcount reductions during January through March 2026.
  • Medical supply careers face separation: McKesson outlined a planned Medical-Surgical IPO alongside Apollo's investment agreement in April 2026.

What makes McKesson unique

  • McKesson backs independent ownership: its Health Mart franchise supports pharmacies that remain independently owned and operated.
  • Generic purchasing has a retail partner: McKesson and Walmart jointly source medicines through ClarusONE.
  • McKesson reaches prescribing workflows: CoverMyMeds processes insurance approval requests free for clinicians across all plans and medications.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Performance Bonus
  • 401(k) Company Match

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
AD HOC NEWS
Oct 15th, 2026
McKesson commits $1.4B for 49% stake in Option Care at $5.8B valuation

McKesson will invest $1.4 billion for a 49% minority stake in Option Care Health, under an agreement announced on October 6, 2026. The deal values Option Care at an enterprise value of $5.8 billion. Clayton, Dubilier & Rice will hold about 51%. Option Care will stay separately managed, while McKesson keeps a framework to acquire the remaining interest later, subject to conditions and regulatory approvals. In its first fiscal 2027 quarter, McKesson reported revenue of $105.38 billion, up 7.7% year on year, and adjusted earnings per share of $9.93. It will report second-quarter results on November 4, 2026.

TradingView
Oct 6th, 2026
CD&R and McKesson to acquire Option Care Health.

CD&R and McKesson to acquire Option Care Health. WASHINGTON (dpa-AFX) - CD&R, McKesson (MCK) and Option Care Health (OPCH) have entered into a definitive agreement, under which CD&R and McKesson will acquire Option Care Health for $32.05 per share, reflecting a total enterprise value of approximately $5.8 billion. Upon completion, Option Care Health will become a privately held company. CD&R will hold a majority interest of approximately 51% in Option Care Health and McKesson will invest approximately $1.4 billion for a minority interest of approximately 49%. The deal establishes a framework for McKesson's future acquisition of CD&R's interest in Option Care Health, subject to specified conditions and regulatory approvals. Option Care Health is an independent provider of home and alternate site infusion services. In pre-market trading on NasdaqGS, Option Care shares are up 20.50 percent to $28.16. For More Such Health News, visit rttnews.com. Copyright(c) 2026 RTTNews.com. All Rights Reserved Copyright RTT News/dpa-AFX Read the full article

JH Consulting Online
Sep 22nd, 2026
Cara McDonough joins McKesson Medical-Surgical as Chief Product Strategy & Supplier Partnerships Officer.

Cara McDonough joins McKesson Medical-Surgical as Chief Product Strategy & Supplier Partnerships Officer. September 22, 2026- McKesson Medical-Surgical has announced that Cara McDonough has joined the organization as Chief Product Strategy & Supplier Partnerships Officer, effective September 14, 2026. In this role, Cara will lead McKesson Medical-Surgical's Product Strategy and Supplier Partnerships teams, guiding supplier relationship strategy and portfolio development across the company's Private Label, Pharmaceutical, Consumer Markets, and Laboratory businesses as a member of the Executive Committee. Cara brings 20 years of experience leading and growing product-focused organizations. Throughout her career, she has held senior leadership positions with nationally recognized companies, driving merchandising, private label, product strategy, and commercial growth across multiple channels, including B2B, e-commerce, and retail. Her experience building differentiated product portfolios, strengthening supplier relationships, and delivering profitable growth aligns closely with the organization's long-term strategy. As McKesson Medical-Surgical continues evolving its business, Cara's leadership will help further strengthen supplier partnerships and support the organization's commitment to delivering innovative solutions and value to customers.

McKesson Corporation
Sep 21st, 2026
McKesson Signs Agreement to Acquire Precision Medicine Group, LLC

McKesson Corporation (NYSE: MCK) announced today that it signed a definitive agreement to acquire Precision Medicine Group, LLC (“Precision Medicine Group”), a global provider of clinical research and biopharma commercialization services.

Compass Oncology
Sep 15th, 2026
Compass Oncology earns first Green Building certification for a medical facility.

Compass Oncology earns first Green Building certification for a medical facility. Sep 15, 2026 What was once a vacant Toys "R" Us and BuyBuy Baby is now setting a new standard for sustainable healthcare At McKesson, Compass Oncology understand that the spaces where Compass Oncology work, distribute and care have a profound impact on its planet and people. In FY24, Compass Oncology developed McKesson's Green Building Standards (GBS) - an internal sustainability framework that provides guidance for eligible building design, construction and operations projects. Across its offices, distribution centers and eligible healthcare buildings, GBS is intended to support environmental performance, operational efficiency and employee well-being. Since inception, Compass Oncology has assessed 52 buildings and achieved 17 GBS certifications, including three Platinum, two Gold, 11 Silver and one Compliant. Compass Oncology, a practice in the US Oncology Network, recently became the first medical building to earn McKesson GBS certification at its East Cancer Center in Happy Valley, Oregon. The achievement is particularly notable because the facility was transformed from a former retail store into a modern healthcare environment developing its East Cancer Center, Compass Oncology partnered with the McKesson Real Estate team to repurpose the existing structure to GBS and create a space designed to support patients, caregivers and employees. Compass Oncology's East Cancer Center earned GBS Silver credit through a range of sustainability and wellness-focused features: * Energy and performance: High-efficiency HVAC systems and STAR appliances * Air Quality & Health: Enhanced air filtration supporting an indoor environment * Water Stewardship: Water-efficient plumbing fixtures that conserve resources * Materials & Carbon Impact: Adaptive reuse strategies that embodied carbon * Wellness & Experience: Bike racks and a thoughtfully designed garden that support employee well-being "At McKesson, we believe advancing health outcomes includes a commitment to creating healthier environments for the people and communities we serve, said Nimesh Jhaveri, R.Ph., Executive Vice President and Chief Impact Officer at McKesson. "Compass Oncology's achievement is an important milestone, not only as the first medical building to earn Green Building Standards certification, but also as a powerful example of how sustainability can be integrated into healthcare settings." Congratulations to Compass Oncology and the McKesson Real Estate team on this pioneering accomplishment!